Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.300
+0.300 (10.00%)
May 13, 2026, 4:25 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 88.96 million as of May 14, 2026. Its market cap has decreased by -25.93% in one year.
Market Cap
88.96M
Enterprise Value
149.14M
Revenue
42.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 88.96M, a decrease of -86.69%. That is a compound annual growth rate of -32.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 88.96M | 0.61% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.79B |
| Thor Medical ASA | 1.59B |
| ArcticZymes Technologies ASA | 1.04B |
| Nykode Therapeutics AS | 1.01B |
| Lytix Biopharma ASA | 815.14M |
| Zelluna ASA | 556.92M |
| SoftOx Solutions AS | 298.98M |
| Oncoinvent ASA | 218.10M |